Intervention group 2: Deferoxamine 50 mg/kg. Frequency and route of administration is once per day continuous IV infusion over 8 hours.
Sponsors
Vice chancellor of research, Shiaz Univeisity of Medical Sciences
Conditions
Hepatic fibrosis.
Hepatic fibrosisacute and chronic cardiopathy.
Heart disease, unspecified
Phase 3
The efficacy of deferoxamine to prevent hepatic fibrosis in children being treated with Anthracyclins
Active, not recruitingIRCT2016080315666N4
Start: 2015-11-01Target: 60Updated: 2018-02-22
deferoxamine and its cardiotoxicity effects
Active, not recruitingIRCT2016080615666N5
Start: 2015-12-01Target: 60Updated: 2018-02-22